Condition
Cochlear Synaptopathy
Total Trials
4
Recruiting
1
Active
1
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 1 (1)
Trial Status
Recruiting1
Terminated1
Completed1
Not Yet Recruiting1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07472907Phase 1Not Yet RecruitingPrimary
A Study Testing the Safety and Possible Benefits of an Ear Injection of a New Compound, Paliroden, in People With Type 2 Diabetes Who Have Difficulty Understanding Speech in Noisy Situations
NCT06114680Not ApplicableTerminated
Evaluation of the CochSyn Test Prototype to Measure Cochlear Synaptopathy
NCT07091071Not ApplicableCompleted
Evaluation of the CochSyn Device in Clinical Practice
NCT07230236Recruiting
Relationship Between LS Chirp ABR and Speech-in-Noise Skills in Hidden Hearing Loss
Showing all 4 trials